Cancer
Cancer Ongoing 2020 Florida

EA1131

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy

Trial overview

Disease
Breast cancer treatment and diagnosis
Topic
EA1131
Description
Primary Objective To compare the IDFS in TNBC patients with residual basal-like disease after neoadjuvant chemotherapy who are randomized to postpreoperative platinum-based chemotherapy with those who are randomized to capecitabine
Physicians

Dr. Mohammad Jahanzeb

MD, FACP, FASCO

Medical Oncologist

Works at 2 centers.

Dr. Edgardo Santos

MD

Medical Oncologist

Aventura (Medical oncology)

Warning: count(): Parameter must be an array or an object that implements Countable in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 288
Location
Warning: count(): Parameter must be an array or an object that implements Countable in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 299

    Warning: Invalid argument supplied for foreach() in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 301